BXRX
Income statement / Annual
Last year (2022), Baudax Bio, Inc.'s total revenue was $1.27 M,
an increase of 17.50% from the previous year.
In 2022, Baudax Bio, Inc.'s net income was -$58.80 M.
See Baudax Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
Operating Revenue |
$1.27 M |
$1.08 M |
$493,000.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$7.01 M
|
$2.45 M
|
$1.73 M
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
-$5.74 M
|
-$1.37 M
|
-$1.24 M
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
-4.52
|
-1.26
|
-2.51
|
0
|
0
|
0
|
Research and Development Expenses |
$5.88 M
|
$3.13 M
|
$9.09 M
|
$20.06 M
|
$35.58 M
|
$28.64 M
|
General & Administrative Expenses |
$14.71 M
|
$0.00
|
$0.00
|
$27.01 M
|
$29.45 M
|
$19.63 M
|
Selling & Marketing Expenses |
$9.41 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$24.12 M
|
$45.31 M
|
$43.34 M
|
$27.01 M
|
$29.45 M
|
$19.63 M
|
Other Expenses |
$0.00
|
$2.58 M
|
$2.15 M
|
-$38,000.00
|
-$132,000.00
|
$16,000.00
|
Operating Expenses |
$30.00 M
|
$51.01 M
|
$54.57 M
|
$47.07 M
|
$65.04 M
|
$48.26 M
|
Cost And Expenses |
$37.01 M
|
$53.46 M
|
$56.30 M
|
$47.07 M
|
$65.04 M
|
$48.26 M
|
Interest Income |
$0.00
|
$0.00
|
$1.36 M
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$21.07 M
|
$2.30 M
|
$1.36 M
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$2.16 M
|
-$29.25 M
|
$21.58 M
|
-$28.63 M
|
$396,000.00
|
$72,000.00
|
EBITDA |
-$35.58 M |
-$48.26 M |
-$74.79 M |
-$39.39 M |
-$56.14 M |
-$35.35 M |
EBITDA Ratio |
-28.04
|
-44.69
|
-107.93
|
0
|
0
|
0
|
Operating Income Ratio |
-28.17
|
-17.6
|
-151.7
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
-$23.05 M
|
$32.61 M
|
-$1.31 M
|
$7.32 M
|
-$8.63 M
|
-$12.82 M
|
Income Before Tax |
-$58.80 M
|
-$19.77 M
|
-$76.10 M
|
-$32.56 M
|
-$73.67 M
|
-$61.08 M
|
Income Before Tax Ratio |
-46.33
|
-18.3
|
-154.36
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$3.84 M
|
$1.40 M
|
-$14.55 M
|
-$132,000.00
|
$12.84 M
|
Net Income |
-$58.80 M
|
-$19.77 M
|
-$76.10 M
|
-$18.00 M
|
-$73.67 M
|
-$61.08 M
|
Net Income Ratio |
-46.33
|
-18.3
|
-154.36
|
0
|
0
|
0
|
EPS |
-177.3 |
-361.16 |
-5715.36 |
-2695.87 |
-11361.35 |
-9420.73 |
EPS Diluted |
-177.3 |
-361.16 |
-5715.36 |
-2695.87 |
-11361.35 |
-9420.73 |
Weighted Average Shares Out |
$331,615.00
|
$54,738.00
|
$13,315.00
|
$6,678.00
|
$6,484.00
|
$6,484.00
|
Weighted Average Shares Out Diluted |
$331,615.00
|
$54,738.00
|
$13,315.00
|
$6,678.00
|
$6,484.00
|
$6,484.00
|
Link |
|
|
|
|
|
|